Product Information

TREMFYA 100 MG/ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $14728.4244 per ML under NDC 57894064001. Its NADAC has been published 127 times since Jun 19, 2024.

TREMFYA 100 MG/ML SYRINGE

Guselkumab
$14728.4244per ML

Strength

100 mg/mL

NDC

57894064001

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

GUSELKUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761061

On Market Since

7/13/2017

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for TREMFYA 100 MG/ML SYRINGE has been published 127 times since Jun 19, 2024, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.

Current price$14728.4244 per ML
All-time high$14779.6320 (Jul 15, 2026)
All-time low$13347.2746 (Jul 17, 2024)
52-week high$14779.6320
52-week low$14066.4145
Median price$14066.4145
Average price$14097.5747
Largest weekly change+5.0% (Feb 5, 2025)
Weeks tracked127
Tracking sinceJun 19, 2024

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.3%

1Y

+4.5%

3Y

N/A

5Y

N/A

All

+10.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TREMFYA 100 MG/ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for TREMFYA 100 MG/ML SYRINGE, manufactured by Janssen Biotech, Inc., is $14728.4244 per ML (NDC 57894064001), effective Nov 18, 2026.

How has the price of TREMFYA 100 MG/ML SYRINGE changed over time?

Over the history we have for it, the NADAC for TREMFYA 100 MG/ML SYRINGE has risen 10.1%. It has been tracked across 127 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for TREMFYA 100 MG/ML SYRINGE?

Since Jun 19, 2024, the NADAC for TREMFYA 100 MG/ML SYRINGE has ranged from a low of $13347.2746 (Jul 17, 2024) to a high of $14779.6320 (Jul 15, 2026), with a median of $14066.4145 per ML.

Are there cheaper alternatives to TREMFYA 100 MG/ML SYRINGE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TREMFYA 100 MG/ML ONE-PRESS, is $14710.6145 per ML — about 0% below TREMFYA 100 MG/ML SYRINGE.

Who manufactures TREMFYA 100 MG/ML SYRINGE?

TREMFYA 100 MG/ML SYRINGE (NDC 57894064001) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.